Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Forlano

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|August 12, 2022
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic ReviewRoberta Forlano, Mathuri Sivakumar, Benjamin H Mullish, et al.
Metabolites|April 28, 2023
Screening for NAFLD-Current Knowledge and ChallengesRoberta Forlano, Giordano Sigon, Benjamin H Mullish, et al.
International Journal of Molecular Sciences|January 21, 2022
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver DiseaseRoberta Forlano, Benjamin H Mullish, Lauren A Roberts, et al.
Biological Imaging|March 21, 2024
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learningSneha N Naik, Roberta Forlano, Pinelopi Manousou, et al.
World Journal of Hepatology|January 24, 2022
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?Roberta Forlano, Benjamin H Mullish, Ameet Dhar, et al.
World Journal of Gastroenterology|March 6, 2019
Current and future pharmacological therapies for managing cirrhosis and its complicationsDavid Kockerling, Rooshi Nathwani, Roberta Forlano, et al.
The International Journal of Eating Disorders|July 17, 2021
Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver diseaseRoberta Forlano, Christopher Harlow, Benjamin H Mullish, et al.
Current Vascular Pharmacology|March 20, 2020
Non-Alcoholic Fatty Liver Disease and Vascular DiseaseRoberta Forlano, Benjamin H Mullish, Rooshi Nathwani, et al.
Nutrients|April 28, 2023
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical PerspectiveJian Huang, Giordano Sigon, Benjamin H Mullish, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Non-alcoholic fatty liver disease in women - Current knowledge and emerging conceptsPei Chia Eng, Roberta Forlano, Tricia Tan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|August 12, 2022
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic ReviewRoberta Forlano, Mathuri Sivakumar, Benjamin H Mullish, et al.
Metabolites|April 28, 2023
Screening for NAFLD-Current Knowledge and ChallengesRoberta Forlano, Giordano Sigon, Benjamin H Mullish, et al.
International Journal of Molecular Sciences|January 21, 2022
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver DiseaseRoberta Forlano, Benjamin H Mullish, Lauren A Roberts, et al.
Biological Imaging|March 21, 2024
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learningSneha N Naik, Roberta Forlano, Pinelopi Manousou, et al.
World Journal of Hepatology|January 24, 2022
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?Roberta Forlano, Benjamin H Mullish, Ameet Dhar, et al.
World Journal of Gastroenterology|March 6, 2019
Current and future pharmacological therapies for managing cirrhosis and its complicationsDavid Kockerling, Rooshi Nathwani, Roberta Forlano, et al.
The International Journal of Eating Disorders|July 17, 2021
Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver diseaseRoberta Forlano, Christopher Harlow, Benjamin H Mullish, et al.
Current Vascular Pharmacology|March 20, 2020
Non-Alcoholic Fatty Liver Disease and Vascular DiseaseRoberta Forlano, Benjamin H Mullish, Rooshi Nathwani, et al.
Nutrients|April 28, 2023
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical PerspectiveJian Huang, Giordano Sigon, Benjamin H Mullish, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Non-alcoholic fatty liver disease in women - Current knowledge and emerging conceptsPei Chia Eng, Roberta Forlano, Tricia Tan, et al.
Pageof 3